{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T12:48:47Z","timestamp":1793710127262,"version":"4.6.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T00:00:00Z","timestamp":1709164800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","jaad.org","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.jaad.2024.02.036","type":"journal-article","created":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T04:07:08Z","timestamp":1709266028000},"page":"64-71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Effects of oral roflumilast therapy on body weight and cardiometabolic parameters in patients with psoriasis \u2013 results from a randomized controlled trial (PSORRO)"],"prefix":"10.1016","volume":"91","author":[{"given":"Mette","family":"Gyldenl\u00f8ve","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer Astrup","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Fage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howraman","family":"Meteran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lone","family":"Skov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Zachariae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip Krag","family":"Knop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia-Louise","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Egeberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jaad.2024.02.036_bib1","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.jaad.2018.11.058","article-title":"Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities","volume":"80","author":"Elmets","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"15","key":"10.1016\/j.jaad.2024.02.036_bib2","first-page":"1492","article-title":"Mechanisms, pathophysiology, and management of obesity","volume":"376","author":"Heymsfield","year":"2017","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.jaad.2024.02.036_bib3","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.3945\/ajcn.2008.26427","article-title":"Weight loss improves the response of obese patients with moderate-to-severe chronic plaque psoriasis to low-dose cyclosporine therapy: a randomized, controlled, investigator-blinded clinical trial","volume":"88","author":"Gisondi","year":"2008","journal-title":"Am J Clin Nutr"},{"issue":"7","key":"10.1016\/j.jaad.2024.02.036_bib4","first-page":"795","article-title":"Effect of weight loss on the severity of psoriasis: a randomized clinical study","volume":"149","author":"Jensen","year":"2013","journal-title":"JAMA\u00a0Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2024.02.036_bib5","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1001\/jamasurg.2016.4610","article-title":"Incidence and prognosis of psoriasis and psoriatic arthritis in patients undergoing bariatric surgery","volume":"152","author":"Egeberg","year":"2017","journal-title":"JAMA Surg"},{"issue":"31","key":"10.1016\/j.jaad.2024.02.036_bib6","doi-asserted-by":"crossref","first-page":"E875","DOI":"10.1503\/cmaj.191707","article-title":"Obesity in adults: a clinical practice guideline","volume":"192","author":"Wharton","year":"2020","journal-title":"CMAJ"},{"issue":"3","key":"10.1016\/j.jaad.2024.02.036_bib7","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S2213-8587(17)30236-X","article-title":"Progress and challenges in anti-obesity pharmacotherapy","volume":"6","author":"Bessesen","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jaad.2024.02.036_bib8","article-title":"Efficacy and safety of oral roflumilast for moderate-to-severe psoriasis-a randomized controlled trial (PSORRO)","volume":"30","author":"Gyldenlove","year":"2023","journal-title":"Lancet Reg Health Eur"},{"issue":"6","key":"10.1016\/j.jaad.2024.02.036_bib9","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1111\/bjd.20602","article-title":"Complete clearance of severe plaque psoriasis with 24 weeks of oral roflumilast therapy","volume":"185","author":"Egeberg","year":"2021","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2024.02.036_bib10","doi-asserted-by":"crossref","first-page":"e429","DOI":"10.1111\/jdv.18647","article-title":"Long-term clearance of severe plaque psoriasis with oral roflumilast","volume":"37","author":"Gyldenlove","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.jaad.2024.02.036_bib11","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa2000073","article-title":"Trial of roflumilast cream for chronic plaque psoriasis","volume":"383","author":"Lebwohl","year":"2020","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.jaad.2024.02.036_bib13","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/bjd.21744","article-title":"Considerable improvement in hidradenitis suppurativa with oral roflumilast therapy","volume":"187","author":"Ring","year":"2022","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2024.02.036_bib14","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/dom.14863","article-title":"Semaglutide for the treatment of overweight and obesity: a review","volume":"25","author":"Bergmann","year":"2023","journal-title":"Diabetes Obes Metab"},{"issue":"9691","key":"10.1016\/j.jaad.2024.02.036_bib15","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(09)61255-1","article-title":"Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials","volume":"374","author":"Calverley","year":"2009","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jaad.2024.02.036_bib16","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/dom.12839","article-title":"The PDE4 inhibitor roflumilast reduces weight gain by increasing energy expenditure and leads to improved glucose metabolism","volume":"19","author":"Mollmann","year":"2017","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"10.1016\/j.jaad.2024.02.036_bib17","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1476-5381.2010.01107.x","article-title":"Role of phosphodiesterase and adenylate cyclase isozymes in murine colonic glucagon-like peptide 1 secreting cells","volume":"163","author":"Friedlander","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jaad.2024.02.036_bib18","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2147\/DMSO.S182953","article-title":"Early effects of roflumilast on insulin sensitivity in adults with prediabetes and overweight\/obesity involve age-associated fat mass loss - results of an exploratory study","volume":"12","author":"Muo","year":"2019","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"10","key":"10.1016\/j.jaad.2024.02.036_bib19","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1007\/s00125-012-2632-z","article-title":"The glucose-lowering effects of the PDE4 inhibitors roflumilast and roflumilast-N-oxide in db\/db mice","volume":"55","author":"Vollert","year":"2012","journal-title":"Diabetologia"},{"issue":"9","key":"10.1016\/j.jaad.2024.02.036_bib20","doi-asserted-by":"crossref","first-page":"E1720","DOI":"10.1210\/jc.2011-2886","article-title":"Effect of the phosphodiesterase 4 inhibitor roflumilast on glucose metabolism in patients with treatment-naive, newly diagnosed type 2 diabetes mellitus","volume":"97","author":"Wouters","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"1-2","key":"10.1016\/j.jaad.2024.02.036_bib21","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.mce.2008.08.012","article-title":"The incretin system and its role in type 2 diabetes mellitus","volume":"297","author":"Holst","year":"2009","journal-title":"Mol Cell Endocrinol"},{"issue":"2","key":"10.1016\/j.jaad.2024.02.036_bib22","first-page":"BC01","article-title":"Oxidative stress and nutritional status in chronic obstructive pulmonary disease","volume":"9","author":"Dhakal","year":"2015","journal-title":"J Clin Diagn Res"},{"issue":"3","key":"10.1016\/j.jaad.2024.02.036_bib23","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1183\/09031936.02.00532002","article-title":"Prognostic value of weight change in chronic obstructive pulmonary disease: results from the Copenhagen city heart study","volume":"20","author":"Prescott","year":"2002","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.jaad.2024.02.036_bib24","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/ajcn\/82.1.53","article-title":"Body composition and mortality in chronic obstructive pulmonary disease","volume":"82","author":"Schols","year":"2005","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"10.1016\/j.jaad.2024.02.036_bib25","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/bjd.18622","article-title":"Clinical characteristics, symptoms and burden of psoriasis and atopic dermatitis in adults","volume":"183","author":"Egeberg","year":"2020","journal-title":"Br J Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2024.02.036_bib26","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/ijo.2015.64","article-title":"Effect of lifestyle weight loss intervention on disease severity in patients with psoriasis: a systematic review and meta-analysis","volume":"39","author":"Upala","year":"2015","journal-title":"Int J Obes (Lond)"},{"issue":"6","key":"10.1016\/j.jaad.2024.02.036_bib27","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1159\/000455840","article-title":"Psoriasis and obesity","volume":"232","author":"Jensen","year":"2016","journal-title":"Dermatology"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962224004262?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962224004262?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T06:37:07Z","timestamp":1722321427000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962224004262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S0190962224004262"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2024.02.036","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of oral roflumilast therapy on body weight and cardiometabolic parameters in patients with psoriasis \u2013 results from a randomized controlled trial (PSORRO)","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2024.02.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American Academy of Dermatology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}